Inventor · disambiguated record
Ashok Gore
Also filed as: GORE ASHOK · GORE ASHOK Y · GORE ASHOK YESHWANT
19 granted patents·6 pending applications·509 citations·filing 1990–2025
96Inventor score
Files withSUPERGEN INC13SPECTRUM PHARMACEUTICALS INC3SUPER GEN INC3UNICYCIVE THERAPEUTICS INC3BASF CORP1
Top patents by PatentIndex Score
25 records- 0194US6319943B1Oral formulation for paclitaxelSUPERGEN INC·Filed 2000·Granted Nov 20, 2001·63 cites·23 claims
- 0293US6538020B2Paclitaxel formulationSUPER GEN INC·Filed 2001·Granted Mar 25, 2003·41 cites·20 claims
- 0393US6509370B1Paclitaxel formulationSUPERGEN INC·Filed 2002·Granted Jan 21, 2003·36 cites·26 claims
- 0493US6136846AFormulation for paclitaxelSUPERGEN INC·Filed 1999·Granted Oct 24, 2000·113 cites·38 claims
- 0591US10350240B2Lanthanum carbonate hydroxide, lanthanum oxycarbonate and methods of their manufacture and useSPECTRUM PHARMACEUTICALS INC·Filed 2013·Granted Jul 16, 2019·27 cites·20 claims
- 0691US6482830B1Compositions and formulations of 9-nitrocamptothecin polymorphs and methods of use thereforSUPERGEN INC·Filed 2002·Granted Nov 19, 2002·27 cites·22 claims
- 0789US7135464B2Method of administering decitabineSUPERGEN INC·Filed 2004·Granted Nov 14, 2006·33 cites·11 claims
- 0886US6710195B2Method for preparing and using polyoxyethylated castor oil in pharmaceutical compositionsSUPERGEN INC·Filed 2002·Granted Mar 23, 2004·21 cites·70 claims
- 0985US6982253B2Liquid formulation of decitabine and use of the sameSUPERGEN INC·Filed 2002·Granted Jan 3, 2006·21 cites·79 claims
- 1082US6492379B1Compositions and formulations of 9-nitrocamptothecin polymorphs and methods of use thereforSUPER GEN INC·Filed 2002·Granted Dec 10, 2002·9 cites·23 claims
- 1179US2025288608A1Lanthanum carbonate hydroxide, lanthanum oxycarbonate and methods of their manufacture and useUNICYCIVE THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1278US7144873B2Kit for delivering decitabine in vivoSUPERGEN INC·Filed 2004·Granted Dec 5, 2006·9 cites·14 claims
- 1378US6017948AWater-miscible pharmaceutical compositionsSUPERGEN INC·Filed 1998·Granted Jan 25, 2000·45 cites·25 claims
- 1475US6696458B2Compositions and formulations of 9-nitrocamptothecin polymorphs and methods of use thereofSUPER GEN INC·Filed 2002·Granted Feb 24, 2004·4 cites·36 claims
- 1574US7071202B2Compositions and formulations of 9-nitrocamptothecin polymorphs and methods of use thereforSUPERGEN INC·Filed 2002·Granted Jul 4, 2006·4 cites·11 claims
- 1673US5262167AEdible, non-baked low moisture cholestyramine compositionBASF CORP·Filed 1990·Granted Nov 16, 1993·52 cites·23 claims
- 1773US2022347210A1Lanthanum Carbonate Hydroxide, Lanthanum Oxycarbonate and Methods of Their Manufacture and UseUNICYCIVE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1871US11406663B2Lanthanum carbonate hydroxide, lanthanum oxycarbonate and methods of their manufacture and useUNICYCIVE THERAPEUTICS INC·Filed 2019·Granted Aug 9, 2022·0 cites·17 claims
- 1970US6756381B2Compositions and formulations of 9-nitrocamptothecin polymorphs and methods of use thereofSUPERGEN INC·Filed 2002·Granted Jun 29, 2004·2 cites·19 claims
- 2069US8961917B2Lanthanum carbonate hydroxide, lanthanum oxycarbonate and methods of their manufacture and useGORE ASHOK YESHWANT·Filed 2011·Granted Feb 24, 2015·2 cites·7 claims
- 2161US2006217407A1Compositions and Formulations of 9-Nitrocamptothecin Polymorphs and Methods of Use ThereforREDKAR SANJEEV·Filed 2006·Application pending·0 cites
- 2255US7049322B2Compositions and formulations of 9-nitrocamptothecin polymorphs and methods of use thereforSUPERGEN INC·Filed 2002·Granted May 23, 2006·0 cites·12 claims
- 2352US2004167205A1Method for preparing and using polyoxyethylated castor oil in pharmaceutical compositionsSUPERGEN INC·Filed 2004·Application pending·0 cites
- 2451US2011251143A1Stable elsamitrucin salt formulationsSPECTRUM PHARMACEUTICALS INC·Filed 2008·Application pending·0 cites
- 2544US2007293445A1Stable Elsamitrucin Salts Suitable for Pharmaceutical FormulationsSPECTRUM PHARMACEUTICALS INC·Filed 2006·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →